Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Gomez

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Frontiers in Medicine|May 21, 2025
Respiratory and other organ manifestations in <i>NKX2-1</i>-related disorders: a systematic reviewKatarzyna Michel, Alba Ruiz-Ramos, Laia Nou-Fontanet, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2023
Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistanceIrma Garcia-Martinez, Rosa Alen, Laura Pereira, et al.
European Journal of Medicinal Chemistry|February 12, 2013
Characterization of a selective CaMKII peptide inhibitorIsabel Gomez-Monterrey, Marina Sala, Maria Rosaria Rusciano, et al.
Journal of Medicinal Chemistry|February 6, 2016
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel ModulatorsAlessia Bertamino, Carmine Ostacolo, Paolo Ambrosino, et al.
Histopathology|March 30, 2023
CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapyMario L Marques-Piubelli, Do Hwan Kim, L Jeffrey Medeiros, et al.
Journal of Medicinal Chemistry|August 14, 2020
Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic ActivitiesAlessia Bertamino, Carmine Ostacolo, Alicia Medina, et al.
European Journal of Medicinal Chemistry|May 22, 2022
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer modelsVeronica Di Sarno, Pia Giovannelli, Alicia Medina-Peris, et al.
Journal of Medicinal Chemistry|June 26, 2018
Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic ActivityAlessia Bertamino, Nunzio Iraci, Carmine Ostacolo, et al.
Journal of Medicinal Chemistry|May 23, 2024
<i>In Silico</i> Assisted Identification, Synthesis, and <i>In Vitro</i> Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 ChannelNunzio Iraci, Lidia Carotenuto, Tania Ciaglia, et al.
Journal of Medicinal Chemistry|August 16, 2022
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant ActivitySimona Musella, Lidia Carotenuto, Nunzio Iraci, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Frontiers in Medicine|May 21, 2025
Respiratory and other organ manifestations in <i>NKX2-1</i>-related disorders: a systematic reviewKatarzyna Michel, Alba Ruiz-Ramos, Laia Nou-Fontanet, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2023
Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistanceIrma Garcia-Martinez, Rosa Alen, Laura Pereira, et al.
European Journal of Medicinal Chemistry|February 12, 2013
Characterization of a selective CaMKII peptide inhibitorIsabel Gomez-Monterrey, Marina Sala, Maria Rosaria Rusciano, et al.
Journal of Medicinal Chemistry|February 6, 2016
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel ModulatorsAlessia Bertamino, Carmine Ostacolo, Paolo Ambrosino, et al.
Histopathology|March 30, 2023
CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapyMario L Marques-Piubelli, Do Hwan Kim, L Jeffrey Medeiros, et al.
Journal of Medicinal Chemistry|August 14, 2020
Exploration of TRPM8 Binding Sites by β-Carboline-Based Antagonists and Their In Vitro Characterization and In Vivo Analgesic ActivitiesAlessia Bertamino, Carmine Ostacolo, Alicia Medina, et al.
European Journal of Medicinal Chemistry|May 22, 2022
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer modelsVeronica Di Sarno, Pia Giovannelli, Alicia Medina-Peris, et al.
Journal of Medicinal Chemistry|June 26, 2018
Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic ActivityAlessia Bertamino, Nunzio Iraci, Carmine Ostacolo, et al.
Journal of Medicinal Chemistry|May 23, 2024
<i>In Silico</i> Assisted Identification, Synthesis, and <i>In Vitro</i> Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 ChannelNunzio Iraci, Lidia Carotenuto, Tania Ciaglia, et al.
Journal of Medicinal Chemistry|August 16, 2022
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant ActivitySimona Musella, Lidia Carotenuto, Nunzio Iraci, et al.
Pageof 10